SCHEMBL8459337

SCHEMBL8459337

COCOCCCc1cc2ccc(OC(=O)c3ccccc3)cc2cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 4/20 0.41
RARG P13631 4/20 0.41
RARA P10276 3/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPT P10636 2/20 0.41
EPHX2 P34913 2/20 0.39
IKBKB O14920 4/20 0.38
LMNA P02545 3/20 0.37
NR1I2 O75469 1/20 0.37
PGR P06401 1/20 0.37
HSPD1 P10809 1/20 0.37
GOT1 P17174 1/20 0.37
GLRA1 P23415 1/20 0.37
BLM P54132 1/20 0.37
HSPE1 P61604 1/20 0.37
THRB P10828 1/20 0.37
RECQL P46063 1/20 0.37
NR2E1 Q9Y466 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8457564 0.95 KMT2A (0.43) RARBRARGRARAKMT2AMEN1
SCHEMBL8461063 0.86 RARB (0.55) RARBRARGRARAKMT2AMEN1
SCHEMBL8460553 0.84 KMT2A (0.48) RARBRARGRARAKMT2AMEN1
SCHEMBL7929975 0.83 RARB (0.50) RARBRARGRARAKMT2AMEN1
SCHEMBL7515995 0.82 MEN1 (0.58) RARBRARGRARAKMT2AMEN1
SCHEMBL8457121 0.81 RARA (0.53) RARBRARGRARAKMT2AMEN1
SCHEMBL7930150 0.78 MEN1 (0.50) RARBRARGRARAKMT2AMEN1
SCHEMBL8574332 0.77 RARA (0.39) RARBRARGRARAKMT2AMEN1
SCHEMBL7926445 0.77 MEN1 (0.61) RARBRARGRARAKMT2AMEN1
SCHEMBL8319272 0.77 KMT2A (0.60) RARBRARGRARAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952382-A INHIBITING THE BIOLOGICAL EFFECTS OF AN OVERREGULATION OF RETINOID ACID RECEPTORS AND/OR OF A HYPERVITAMINOSIS A; TREATING SKIN DISORDER, EYE VISION DEFECTS, SKIN AGING CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1999-09-14 US claimed
US-5952382-A INHIBITING THE BIOLOGICAL EFFECTS OF AN OVERREGULATION OF RETINOID ACID RECEPTORS AND/OR OF A HYPERVITAMINOSIS A; TREATING SKIN DISORDER, EYE VISION DEFECTS, SKIN AGING CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1999-09-14 US disclosed